Lupin Pharmaceuticals Inc. has voluntarily recalled 7,215 bottles of Cephalexin for Oral Suspension USP, 250mg/5mL (200 mL when mixed). This prescription antibiotic was recalled because the company could not locate the required manufacturing batch records, which is a deviation from Current Good Manufacturing Practice (CGMP) standards. While no specific patient injuries or product defects have been reported, the lack of documentation means the quality and safety of these specific bottles cannot be fully verified. Consumers should contact their healthcare provider or pharmacist for guidance on how to handle their remaining medication.
The absence of manufacturing batch records means the producer cannot prove that this specific lot was made according to safety and quality standards. This creates a potential risk that unknown defects or contamination could exist, which might lead to ineffective treatment or unexpected side effects.
Contact healthcare provider and return product for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.